SCHEMBL6763386

SCHEMBL6763386

N#Cc1ccc(Oc2ccc3c(c2)CC(N)C(=O)N3O)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AADAT Q8N5Z0 14/20 0.74
KYAT3 Q6YP21 4/20 0.74
KYAT1 Q16773 3/20 0.74
GOT1 P17174 1/20 0.49
CHRM1 P11229 1/20 0.42
PDE4A P27815 1/20 0.42
ADRA1A P35348 1/20 0.42
PDE1A P54750 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
PDE3B Q13370 1/20 0.42
PDE7A Q13946 1/20 0.42
PDE3A Q14432 1/20 0.42
PARP15 Q460N3 1/20 0.41
PARP10 Q53GL7 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
MMP8 P22894 2/20 0.40
MMP3 P08254 1/20 0.40
SCN9A Q15858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3777393 0.90 AADAT (0.73) AADATKYAT3KYAT1GOT1PDE4A
SCHEMBL16612916 0.86 AADAT (0.63) AADATKYAT3KYAT1GOT1
SCHEMBL3779058 0.86 AADAT (0.63) AADATKYAT3KYAT1GOT1
SCHEMBL2143232 0.85 AADAT (1.00) AADATKYAT3KYAT1GOT1
SCHEMBL6763345 0.84 AADAT (0.79) AADATKYAT3KYAT1GOT1
SCHEMBL6763381 0.84 AADAT (0.79) AADATKYAT3KYAT1GOT1
SCHEMBL6763507 0.84 AADAT (0.79) AADATKYAT3KYAT1GOT1
SCHEMBL6763411 0.84 AADAT (0.79) AADATKYAT3KYAT1GOT1
SCHEMBL6763400 0.83 AADAT (0.77) AADATKYAT3KYAT1GOT1
SCHEMBL3776005 0.82 AADAT (0.50) AADATKYAT3KYAT1GOT1PARP15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443092-B1 BICYCLIC AND TRICYCLIC COMPOUNDS AS KAT II INHIBITORS PFIZER (US) 2015-04-08 EP disclosed
US-8183238-B2 Bicyclic and tricyclic compounds as KAT II inhibitors PFIZER INC. (US) 2012-05-22 US disclosed
US-8183238-B2 Bicyclic and tricyclic compounds as KAT II inhibitors PFIZER INC. (US) 2012-05-22 US disclosed
US-20100324043-A1 Bicyclic And Tricyclic Compounds As KAT II Inhibitors PFIZER INC 2010-12-23 US disclosed
US-20100324043-A1 Bicyclic And Tricyclic Compounds As KAT II Inhibitors PFIZER INC 2010-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324043-A1 Bicyclic And Tricyclic Compounds As KAT II Inhibitors KAT2A, KAT2B, KAT6B AADAT 2284/4885KYAT3 129/4885KYAT1 69/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.